Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
trastuzumab (herceptin) (1 trial)
carboplatin (paraplatin) (1 trial)
gemcitabine (gemzar) (1 trial)
paclitaxel (taxol) (1 trial)
autologous microbiome (1 trial)
Breast Neoplasms (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (5 total)